Comprehensive GMP audits for pharmaceutical, biotech, API, and medical device manufacturers, identifying compliance gaps and protecting product quality before regulators do.
Good Manufacturing Practice compliance is the foundation of pharmaceutical product safety and quality. GxP Global Quality Network provides thorough, systematic GMP audits that go beyond checklist compliance, Network auditors deliver actionable intelligence that strengthens your manufacturing operations and reduces regulatory risk.
Led by Monica Brooks, MSc, engagements draw on over two decades of pharmaceutical industry experience, covering finished dose form manufacturers, API producers, contract manufacturers (CMOs/CDMOs), and raw material suppliers.
Every GMP audit engagement concludes with a comprehensive written audit report including: executive summary, detailed observations categorized by risk (Critical/Major/Minor), regulatory references, root cause analysis, and a recommended CAPA action plan, all delivered within agreed timelines.
We also provide follow-up support for CAPA implementation tracking, re-audits, and regulatory response preparation as needed.
Quality standard: All GxP Global Quality Network engagements are led by senior-credentialed auditors with 20+ years of active GxP audit experience, regulatory currency across FDA, EMA, MHRA, and Health Canada standards, and direct accountability for every deliverable.